According to our new report entitled “Global Contract Manufacturing Market Analysis”, the global contract manufacturing market has been witnessing a rapid growth rate pattern for the past few years. This development is backed by factors, such as strong demand for pharmaceuticals, increasing private investments, and rapid economic growth in the developing market. The global pharmaceutical contact manufacturing industry reached to the value of around US$ 22.5 Billion in 2009, and is further likely to reach nearly US$ 34 Billion by 2013, growing at a CAGR of around 11% since 2011.
Our report has found that, China offers advantages, such as advanced manufacturing capabilities and good quality facilities that set it apart from neighbors like India and Vietnam. Moreover, low production cost and minimum taxes on production are among other factors that are driving growth in the Chinese pharmaceutical manufacturing industry. It is estimated that, China’s finished drugs trade will grow at a CAGR of 7.3% during 2011-2013.
The report “Global Contract Manufacturing Market Analysis” broadly investigates the current trends prevailing in the market and discusses their impact on the sector performance. The report properly analyzes the market structure and size in different countries and elaborates key developments. It also covers a section on the current market issues that need to be acknowledged by all the entities involved.
The report covers all the key aspects of the global contract manufacturing market and provides clients with reliable statistics and data. Forecast in the key market areas makes use of effective methods and techniques that seek to present a realistic future overview. Last though not the least, the description and recent developments related to key market players completes the picture.
For more information visit: http://www.rncos.com/Report/IM265.htm |
